5AM Ventures IV L.P. 13D/13G Filings for Aprea Therapeutics, Inc. (APRE)

5AM Ventures IV L.P. 13D and 13G filings for Aprea Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-02-16
5:08 pm
Sale		 2021-02-11 13D Aprea Therapeutics, Inc.
APRE		 5AM Ventures IV L.P. 30,958
13.000%		 -37,925decrease
(-55.06%)		 Filing
2020-11-19
4:27 pm
Sale		 2020-11-16 13D Aprea Therapeutics, Inc.
APRE		 5AM Ventures IV L.P. 68,883
6.500%		 -33,000decrease
(-32.39%)		 Filing
2020-10-07
5:00 pm
Sale		 2020-10-05 13D Aprea Therapeutics, Inc.
APRE		 5AM Ventures IV L.P. 101,883
9.600%		 -15,750decrease
(-13.39%)		 Filing
2020-06-15
7:13 pm
Sale		 2020-06-11 13D Aprea Therapeutics, Inc.
APRE		 5AM Ventures IV L.P. 117,633
11.200%		 -12,250decrease
(-9.43%)		 Filing
2020-05-21
8:38 pm
Sale		 2020-05-19 13D Aprea Therapeutics, Inc.
APRE		 5AM Ventures IV L.P. 129,883
12.300%		 -12,750decrease
(-8.94%)		 Filing